Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel–cisplatin versus vinorelbine–cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study-Reference-Cited by-同舟云学术

Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel–cisplatin versus vinorelbine–cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study

Published:2005-01 Issue:1 Volume:16 Page:81-89
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Douillard J.-Y.,Gervais R.,Dabouis G.,Le Groumellec A.,D'Arlhac M.,Spaeth D.,Coudert B.,Caillaud D.,Monnier A.,Clary C.,Maury B.,Mornet M.,Rivière A.,Clouet P.,Couteau C.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/16/1/81/434542/mdi013.pdf

Reference23 articles.

1. Cancer statistics 2002;Jemal;CA Cancer J Clin,2002

2. Chemotherapy in NSCLC: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;Non-small Cell Lung Cancer Collaborative Group;BMJ,1995

3. Chemotherapy can prolong survival with advanced non-small cell lung cancer. Report of a Canadian multicenter randomized trial;Rapp;J Clin Oncol,1988

4. Prospective randomized trial of docetaxel versus best supportive care in patients with non small-cell lung cancer previously treated with cisplatin based chemotherapy;Shepherd;J Clin Oncol,2000

5. Randomized phase III trial of docetaxel vs vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens;Fossella;J Clin Oncol,2000

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The best regimens for chemo-naïve incurable non-squamous non- small cell lung cancer with a programmed death-ligand 1, tumor proportion score 1–49%: a network meta-analysis;Translational Lung Cancer Research;2021-08

2. Switching from Thoracoscopic to Robotic Platform for Lobectomy: Report of Learning Curve and Outcome;Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery;2020-03-31

3. A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer;Journal of Thoracic Disease;2019-08

4. A multi species evaluation of the radiation dosimetry of [ 11 C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor;Nuclear Medicine and Biology;2017-04

5. Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches;International Journal of Molecular Sciences;2016-09-13